FREE TREATMENT REPORT

See ratings and reviews when you sign up for an account.

Assessment and Follow Up Study of Children and Adolescent With Bipolar Disorder

This study is currently Recruiting

October 2009 By Federal University of Rio Grande do Sul

First Recieved on October 22, 2009

Last Updated on October 22, 2009

Sponsor: Federal University of Rio Grande do Sul
Collaborators: Hospital de Clinicas de Porto Alegre
Information provided by: Federal University of Rio Grande do Sul
Identifier: NCT01000402

Purpose

This is an outpatient program for children and adolescents with bipolar disorders. The naturalistic approach of the program will allow a proper investigation of the disorder, assessment of environmental and biological factors, the conduction of treatment studies, and follow-up of the subjects.

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

Eligibility

Ages Eligible for Study:6 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:Accepts Healthy Volunteers
Criteria

Inclusion Criteria: - 6-18 years-old; - Bipolar Disorder I, II or NOS - Severe Mood Dysregulation Exclusion Criteria: - Schizophrenia - Pervasive Developmental Disorder - Drug use disorder - Severe suicidal or homicidal risk, counterindicating outpatient treatment

Investigators

  • Investigator: Luis A Rohde, D.Sc. - Principal Investigator - Federal University of Rio Grande do Sul

Locations

  • Hospital de Clinicas de Porto Alegre

    Porto Alegre, RS 90350-903 Brazil

advertisement
V2012.311.925.327
Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.